In turn, ANCA-negative EGPA has a mucosal barrier origin and is associated with variants of the glycoprotein A33 (GPA33) and IL-5/interferon regulatory factor 1 (IRF1) (genotype sharing with asthma). This evidence concerns the gene IL5 and eosinophilic granulomatosis with polyangiitis.